Literature DB >> 11122110

The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma.

L K Goff1, M J Neat, C R Crawley, L Jones, E Jones, T A Lister, R K Gupta.   

Abstract

Using comparative genomic hybridization (CGH), aberrations in DNA copy number were studied before and after transformation of follicular lymphoma to diffuse large B-cell lymphoma in six patients (15 lymph node biopsies in total). The most common and also the most discrete and intense amplification occurring in four out of 15 biopsies from three different patients was of 2p13-16. Using real-time quantitative polymerase chain reaction (RQ-PCR), REL amplification was found to be implicated at this locus. This technique also identified amplified REL in a further two biopsies, presumably below the detection level of CGH. REL amplification was quantified by comparing it, in most cases, with three endogenous reference genes, albumin, beta2-microglobulin and CD8alpha, that lie close to REL on 2p. There was no correlation apparent between 2p13-16 amplification or REL amplification and transformation. This study shows the usefulness of coupling CGH, for detecting recurring abnormalities, with the real-time PCR technique for rapid gene dosage quantification and confirms that the REL gene is a potential candidate in the pathogenesis of a particular subset of follicular lymphomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122110     DOI: 10.1046/j.1365-2141.2000.02352.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

1.  Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression.

Authors:  Brygida Bisikirska; Mukesh Bansal; Yao Shen; Julie Teruya-Feldstein; Raju Chaganti; Andrea Califano
Journal:  Cancer Res       Date:  2015-11-20       Impact factor: 12.701

2.  Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.

Authors:  Andrew J Davies; Andreas Rosenwald; George Wright; Abigail Lee; Kim W Last; Dennis D Weisenburger; Wing C Chan; Jan Delabie; Rita M Braziel; Elias Campo; Randy D Gascoyne; Elaine S Jaffe; Konrad Muller-Hermelink; German Ott; Maria Calaminici; Andrew J Norton; Lindsey K Goff; Jude Fitzgibbon; Louis M Staudt; T Andrew Lister
Journal:  Br J Haematol       Date:  2007-01       Impact factor: 6.998

3.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

4.  Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling.

Authors:  Kai Fu; Dennis D Weisenburger; Timothy C Greiner; Sandeep Dave; George Wright; Andreas Rosenwald; Michael Chiorazzi; Javeed Iqbal; Stefan Gesk; Reiner Siebert; Daphne De Jong; Elaine S Jaffe; Wyndham H Wilson; Jan Delabie; German Ott; Bhavana J Dave; Warren G Sanger; Lynette M Smith; Lisa Rimsza; Rita M Braziel; H Konrad Müller-Hermelink; Elias Campo; Randy D Gascoyne; Louis M Staudt; Wing C Chan
Journal:  Blood       Date:  2005-08-25       Impact factor: 22.113

5.  The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability.

Authors:  Michael Overholtzer; Pulivarthi H Rao; Reyna Favis; Xin-Yan Lu; Michael B Elowitz; Francis Barany; Marc Ladanyi; Richard Gorlick; Arnold J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

6.  Quantification of designer nuclease induced mutation rates: a direct comparison of different methods.

Authors:  Eric Ehrke-Schulz; Thorsten Bergmann; Maren Schiwon; Johannes Doerner; Kamola Saydaminova; Andre Lieber; Anja Ehrhardt
Journal:  Mol Ther Methods Clin Dev       Date:  2016-07-06       Impact factor: 6.698

7.  Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers.

Authors:  Takafumi Watanabe; Issei Imoto; Tomoyuki Katahira; Akira Hirasawa; Isamu Ishiwata; Mitsuru Emi; Masaomi Takayama; Akira Sato; Johji Inazawa
Journal:  Jpn J Cancer Res       Date:  2002-10

8.  High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours.

Authors:  D M Lillington; L K Goff; J E Kingston; Z Onadim; E Price; P Domizio; B D Young
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

9.  Principles and applications of polymerase chain reaction in medical diagnostic fields: a review.

Authors:  Marcela Agne Alves Valones; Rafael Lima Guimarães; Lucas André Cavalcanti Brandão; Paulo Roberto Eleutério de Souza; Alessandra de Albuquerque Tavares Carvalho; Sergio Crovela
Journal:  Braz J Microbiol       Date:  2009-03-01       Impact factor: 2.476

10.  Amplification of 2p as a genomic marker for transformation in lymphoma.

Authors:  Anna Kwiecinska; Koichi Ichimura; Mattias Berglund; Andrii Dinets; Luqman Sulaiman; V Peter Collins; Catharina Larsson; Anna Porwit; Svetlana Bajalica Lagercrantz
Journal:  Genes Chromosomes Cancer       Date:  2014-05-15       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.